January 2017 Issue Table Of Contents

From The Editor
Feature Articles
Capitol Perspectives
Companies To Watch
CEO Corner
Inside The Industry
- Why Pet Health Is The Focus Of A New Biotech Sector
- How Boehringer Ingelheim Is Redefining Its R&D Strategy
- Cell Therapy Regulations Approach Their Inflection Point
- Orphan Drug Incentives & Innovations On The Rise
- Biotech Bounces Back: A Tale Of Two Companies
- Janssen Uses Trial Simulations To Capture Patient Concerns
- Beyond Oncology — Precision Medicine For Autoimmune Diseases
Leadership Lessons
Industry Leader
Ask The Board
This website uses cookies to ensure you get the best experience on our website. Learn more